Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2016-07-29
Original market date: See footnote 1
1987-12-31
Product name:
AMINOSYN II 7% INJECTION
DIN:
00742635
Product Monograph/Veterinary Labelling:
Date:
2012-06-01
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
HOSPIRA HEALTHCARE ULC
17300 Trans-Canada Highway
Kirkland
Quebec
Canada
H9J 2M5
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
17
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
40:20.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
B05BA01 AMINO ACIDS
Active ingredient group (AIG) number:See footnote5
1750888004
Active ingredient(s) See footnote8 | Strength |
---|---|
GLUTAMIC ACID | 517 MG / 100 ML |
GLYCINE | 350 MG / 100 ML |
HISTIDINE | 210 MG / 100 ML |
L-ALANINE | 695 MG / 100 ML |
L-ARGININE | 713 MG / 100 ML |
L-ASPARTIC ACID | 490 MG / 100 ML |
L-ISOLEUCINE | 462 MG / 100 ML |
L-LEUCINE | 700 MG / 100 ML |
L-LYSINE (L-LYSINE ACETATE) | 735 MG / 100 ML |
L-PHENYLALANINE | 209 MG / 100 ML |
L-PROLINE | 505 MG / 100 ML |
L-THREONINE | 280 MG / 100 ML |
L-VALINE | 350 MG / 100 ML |
METHIONINE | 120 MG / 100 ML |
N-ACETYL-L-TYROSINE | 189 MG / 100 ML |
SERINE | 371 MG / 100 ML |
TRYPTOPHAN | 140 MG / 100 ML |